Farmeconomia-Health Economics and Therapeutic Pathways

Scope & Guideline

Empowering evidence-based healthcare with insightful research.

Introduction

Explore the comprehensive scope of Farmeconomia-Health Economics and Therapeutic Pathways through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Farmeconomia-Health Economics and Therapeutic Pathways in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN1721-6915
PublisherSEED MEDICAL PUBLISHERS
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationFARMECONOMIA / Farmeconomia
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVIA MAGENTA, 35, TORINO 10128, ITALY

Aims and Scopes

The journal 'Farmeconomia-Health Economics and Therapeutic Pathways' focuses on the intersection of health economics and therapeutic strategies. It aims to provide insights into the economic aspects of healthcare decisions, emphasizing cost-effectiveness, budget impact, and quality of life assessments in various therapeutic areas.
  1. Health Economics and Pharmacoeconomics:
    The journal emphasizes the economic evaluation of healthcare interventions, including cost-effectiveness analyses and pharmacoeconomic assessments to inform drug pricing and reimbursement decisions.
  2. Health Technology Assessment (HTA):
    It covers comprehensive evaluations of health technologies, assessing their clinical effectiveness, safety, and economic impact, which is essential for informed policy-making.
  3. Real-World Evidence (RWE):
    The journal highlights the importance of real-world evidence in understanding treatment effectiveness and patient outcomes outside controlled clinical trials.
  4. Patient-Centered Outcomes:
    Research often focuses on the impact of treatments on patient quality of life and healthcare resource utilization, ensuring that patient perspectives are central to economic evaluations.
  5. Cost Analysis in Specific Disease Areas:
    The scope includes detailed economic analyses for various diseases, such as diabetes, cancer, and mental health disorders, providing insights into the financial implications of different treatment strategies.
The journal is currently witnessing several emerging themes that reflect the evolving landscape of healthcare economics and therapeutic pathways. These trends highlight the increasing complexity of healthcare decisions and the importance of comprehensive evaluations.
  1. Long-Acting Injectable Therapies:
    There is a growing focus on the clinical and economic potential of long-acting injectable therapies, particularly in mental health and chronic conditions, reflecting a shift towards treatments that improve adherence and outcomes.
  2. Biosimilars and Their Economic Implications:
    Research on biosimilars, including their procurement and budget impact, is trending upward as healthcare systems look for cost-effective alternatives to expensive biologics.
  3. Budget Impact Analyses in Vaccination Programs:
    The importance of budget impact analyses in vaccination strategies, particularly for influenza and other vaccines, is gaining traction as public health priorities shift towards preventative healthcare.
  4. Integrated Care Models and Multi-Disease Approaches:
    Emerging studies are increasingly examining integrated care models that address multiple chronic conditions simultaneously, reflecting a holistic approach to patient management and economic evaluation.
  5. Use of Wearable Health Technologies:
    The assessment of wearable health technologies and their impact on patient management and health outcomes is becoming a prominent theme, driven by advancements in technology and patient engagement.

Declining or Waning

While the journal maintains a robust focus on health economics and therapeutic pathways, certain themes appear to be losing prominence in recent publications. This may reflect shifts in the healthcare landscape or emerging priorities in research.
  1. Traditional Cost-Benefit Analyses:
    There has been a noticeable decline in traditional cost-benefit analyses that do not incorporate broader patient-centered outcomes or real-world evidence, suggesting a shift towards more comprehensive evaluation frameworks.
  2. Generic Drug Assessments:
    Research specifically focused on the economic evaluation of generic drugs seems to be waning, potentially due to a saturation of studies in this area and a preference for innovative therapies.
  3. Single-Disease Focus Studies:
    There appears to be a reduction in studies concentrating solely on single-disease economic evaluations, with an increasing trend toward integrated care models that consider multiple conditions and their interactions.
  4. Basic Economic Modelling Techniques:
    The journal has seen fewer publications relying on basic economic modelling techniques, with a growing preference for sophisticated models that incorporate real-world complexities and uncertainties.

Similar Journals

MEDICAL DECISION MAKING

Leading the way in health policy insights since 1981.
Publisher: SAGE PUBLICATIONS INCISSN: 0272-989XFrequency: 8 issues/year

Medical Decision Making is a premier journal published by SAGE Publications Inc, dedicated to advancing the field of health policy through rigorous research, innovative methodologies, and comprehensive analyses. Since its inception in 1981, it has established itself as a leading platform for disseminating significant findings, and it proudly holds a Q1 ranking in the health policy category, underscoring its commitment to excellence within the academic community. With an impressive Scopus rank of 43 out of 310, the journal ranks in the top 14% of its field, reflecting its influential contributions to medical decision-making processes. Medical Decision Making serves a diverse audience of researchers, practitioners, and policymakers by providing scholarly articles that blend theoretical insights with practical applications, ultimately improving patient care and health outcomes. The journal's dedicated following and its continued relevance through to 2024 position it as an essential resource for anyone vested in the evolution and implementation of effective health policies.

Journal of Comparative Effectiveness Research

Shaping the future of health policy through innovative research.
Publisher: Becaris PublishingISSN: 2042-6305Frequency: 18 issues/year

Journal of Comparative Effectiveness Research is a leading academic journal dedicated to the evaluation of healthcare interventions and practices, published by Becaris Publishing. Since transitioning to a fully Open Access model in 2023, the journal has expanded its accessibility to a global audience of researchers, healthcare professionals, and policy makers. With a focus on comparative effectiveness in health policy, it has achieved a notable ranking of #132 out of 310 in the Scopus category for Medicine and Health Policy, placing it in the 57th percentile for scholarly impact. Operating from the United Kingdom, the journal encompasses research from 2012 to 2024 and firmly establishes itself in the academic landscape as a Q2 journal in the Health Policy category as of 2023. By disseminating high-quality, evidence-based research, the Journal of Comparative Effectiveness Research plays a vital role in informing clinical practice and health policy decision-making, making it an essential resource for those dedicated to improving health outcomes.

Gesundheitsoekonomie und Qualitaetsmanagement

Fostering Excellence in Health Economics and Quality Management
Publisher: THIEME MEDICAL PUBL INCISSN: 1432-2625Frequency: 6 issues/year

Gesundheitsoekonomie und Qualitaetsmanagement, published by THIEME MEDICAL PUBL INC, serves as a vital resource in the field of health policy, particularly within the context of Germany. Since its inception in 1999, this journal has been committed to advancing the discourse on health economics and quality management, making significant contributions to understanding the complexities of healthcare systems. With an impact factor that reflects its ongoing importance, the journal is categorized in the Q4 quartile for Health Policy as of 2023, indicating its role in serving a niche yet crucial space in medical literature. Although currently not an open access journal, it remains accessible through various academic platforms, making its content available to a diverse audience of researchers, healthcare professionals, and students eager to engage with contemporary issues in health economics. With its publication continuing through 2024, Gesundheitsoekonomie und Qualitaetsmanagement is essential for anyone looking to deepen their understanding of the economic aspects of healthcare and ensure quality management in health services.

Health Economics Review

Empowering decision-makers with robust economic evaluations.
Publisher: BMCISSN: 2191-1991Frequency: 1 issue/year

Health Economics Review is a premier, peer-reviewed journal dedicated to advancing knowledge and research in the dynamic field of health economics and policy. Published by BMC, this Open Access journal has been a vital resource since 2011, providing a platform for scholars and practitioners to share their findings and insights on pressing health policy issues. With an impressive Q2 ranking in the Health Policy category and a Scopus rank of 113 out of 310, it reflects a solid standing within the academic community, capturing a 63rd percentile ranking that underscores its contribution to the field. The journal covers an extensive range of topics including health systems, economic evaluations, and policy analysis, making it essential reading for researchers, health professionals, and policymakers. Located in Germany, with an operational address at CAMPUS, 4 Crinan St, London, the journal is committed to fostering innovation and collaboration in health economics, thereby shaping a healthier future for all.

Health Policy and Technology

Transforming healthcare through policy and innovation.
Publisher: ELSEVIER SCI LTDISSN: 2211-8837Frequency: 4 issues/year

Health Policy and Technology is a prestigious academic journal published by ELSEVIER SCI LTD that has established itself as a leader in the fields of Biomedical Engineering and Health Policy. With an impressive Q1 ranking in both disciplines as of 2023, the journal offers a platform for original research, reviews, and innovative technological solutions that aim to bridge the gap between health policy and technology. Since its inception in 2012, it has served as a vital resource for researchers, professionals, and students who are seeking to explore the impact of technology on healthcare systems and policies globally. Although it is not an open-access journal, the high-quality, peer-reviewed articles published within its pages contribute significantly to the discourse on the advancement of healthcare practices. The journal's commitment to disseminating groundbreaking studies ensures it remains a crucial reference point in these rapidly evolving fields.

ADVANCES IN THERAPY

Bridging research and practice in therapeutic advancements.
Publisher: SPRINGERISSN: 0741-238XFrequency: 12 issues/year

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

Applied Health Economics and Health Policy

Innovating health solutions through economic evaluation.
Publisher: SPRINGER INT PUBL AGISSN: 1175-5652Frequency: 6 issues/year

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.

Cost Effectiveness and Resource Allocation

Empowering Decisions for Effective Resource Allocation
Publisher: BMCISSN: 1478-7547Frequency: 1 issue/year

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

HEALTH TECHNOLOGY ASSESSMENT

Elevating healthcare standards through critical technology evaluation.
Publisher: NIHR JOURNALS LIBRARYISSN: 1366-5278Frequency:

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

VALUE IN HEALTH

Driving Change in Public Health Through Scholarly Excellence
Publisher: ELSEVIER SCIENCE INCISSN: 1098-3015Frequency: 12 issues/year

VALUE IN HEALTH, published by Elsevier Science Inc, is a premier peer-reviewed journal in the fields of Health Policy, Medicine, and Public Health. With an impressive impact factor reflecting its respected standing, the journal has achieved a distinguished Q1 classification in multiple categories, placing it among the top publications in the health domain. Since its inception in 1998, this journal has been a vital platform for disseminating research that informs health policy and practice, impacting both clinical and public health decision-making. The journal’s Scopus rankings further underscore its global influence, with notable positions in Medicine and Public Health sectors. VALUE IN HEALTH is committed to fostering an environment where innovative research meets practical application, ultimately aiming to enhance health outcomes worldwide. Researchers, professionals, and students alike are encouraged to explore the wealth of knowledge contained within its pages.